You searched for apixaban - MPR

Your search for apixaban returned 97 results

Your search for apixaban returned 97 results

Sort Results:

Relevant Recent
Drug Monograph

ELIQUIS

Apixaban 2.5mg, 5mg; tabs.
Drugs in the Pipeline

Eliquis Reversal Agent Demonstrates Efficacy in Phase 3 Study

Portola Pharmaceuticals, Bristol-Myers Squibb Company, and Pfizer announced results from the Phase 3 ANNEXA-A (Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of FXa Inhibitors - Apixaban) study with andexanet alfa as a reversal agent for Eliquis (apixaban).
News

Prophylaxis With Apixaban Feasible for Cancer Patients

Primary venous thromboembolism prophylaxis with apixaban, an oral direct Factor Xa inhibitor, in ambulatory cancer patients undergoing first- or second-line chemotherapy for advanced or metastatic cancer, is safe and well tolerated.